Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Eva Kohnert
Correction: Microbial evaluation of zirconia and titanium implants in the anterior mandibula: a randomized controlled clinical trial
Correction to: Scientific Reports https://doi.org/10.1038/s41598-026-54915-0, published online 03 June 2026 The original version of this Article contained an error in the spelling of the author Konstantin J. Scholz which was incorrectly given as Konstantin Scholz. The original Article has been corrected.
Microbial evaluation of zirconia and titanium implants in the anterior mandibula: a randomized controlled clinical trial
Abstract To evaluate the effect of the implant material—either titanium or zirconia—on the development of bacterial deposits. In this one-year prospective split-mouth study, 20 patients with an edentulous lower jaw were treated with two zirconia and two titanium implants. Clip attachments were used for the removable denture.
Gut Microbiota in Diagnosis, Therapy and Prognosis of Cholangiocarcinoma and Gallbladder Carcinoma-A Scoping Review
1. Introduction Biliary tract cancer (BTC) is an overall rare, but highly lethal cancer entity [,]. Globally, BTC is much more common in Asia with incidence rates of more than 80 persons per 100,000 per year, e.g., in Thailand compared to an incidence of approximately 1–2 person per 100,000 in Western countries []. Recent epidemiological studies have shown a general increase in incidence over the last 20 years [,].
Changes in Gut Microbiota after a Four-Week Intervention with Vegan vs. Meat-Rich Diets in Healthy Participants: A Randomized Controlled Trial
clear search menu Search for Articles: Logical OperatorOperator Submit to this Journal Review for this Journal Edit a Special Issue Article Menu /ajax/scifeed/subscribe Need Help? Support Find support for a specific problem in the support section of our website. Get Support Feedback Please let us know what you think of our products and services. Give Feedback Information Visit our dedicated information section to learn more about MDPI.
Small Molecule Targets TMED9 and Promotes Lysosomal Degradation to Reverse Proteinopathy
Highlights • Mutant MUC1-fs is toxic to kidney cells by accumulating in TMED9-enriched vesicles • BRD4780 binds cargo receptor TMED9, releases MUC1-fs, and re-routes it to lysosome • MUC1-fs is cleared from kidneys of knockin mice and patient kidney organoids • BRD4780 is a promising lead for the treatment of toxic proteinopathies Summary Intracellular accumulation of misfolded proteins causes toxic proteinopathies, diseases without targeted therapies.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Eva
Contact Eva, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack